Johnson & Johnson Receives Positive CHMP Opinion Recommending Full Approval For Sirturo For Treatment Of Multidrug-Resistant Tuberculosis
Johnson & Johnson +0.38% Pre
Johnson & Johnson JNJ | 163.45 163.45 | +0.38% 0.00% Pre |
- Reuters
Johnson & Johnson Receives Positive CHMP Opinion Recommending Full Approval For Sirturo For Treatment Of Multidrug-Resistant Tuberculosis
Johnson & Johnson JNJ | 163.45 163.45 | +0.38% 0.00% Pre |
- Reuters